THE POTENTIAL IMPACT OF LONG-TERM NUCLEOSIDE THERAPY ON THE MORTALITY AND MORBIDITY OF HIGH VIREMIC CHRONIC HEPATITIS B

被引：0
|
作者：
Toy, Mehlika [1 ]
Veldhuijzen, Irene K. [2 ,3 ]
De Mon, Robert A. [3 ]
Richardus, Jan Hendrik [1 ,2 ]
Schalm, Solko W. [3 ]
机构：
[1] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
[2] Municipal Publ Hlth Serv Rotterdam Rijnmond, Div Infect Dis Control, Rotterdam, Netherlands
[3] Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
来源：
HEPATOLOGY | 2008年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
916
引用
收藏
页码：717A / 717A
页数：1
相关论文
共 50 条
  • [21] Hepatitis B virus (HBV) mutations during long-term therapy in chronic hepatitis B patients
    Arrese, E.
    Basaras, M.
    Blanco, S.
    Ruiz, P.
    Cisterna, R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E233 - E234
  • [22] Long-term clinical impact of occult hepatitis B virus infection in chronic hepatitis B patients
    Komori, M
    Yuki, N
    Nagaoka, T
    Yamashiro, M
    Mochizuki, K
    Kaneko, A
    Yamamoto, K
    Hikiji, K
    Kato, M
    JOURNAL OF HEPATOLOGY, 2001, 35 (06) : 798 - 804
  • [23] Impact of the Pneumococcal Vaccine on Long-Term Morbidity and Mortality of Adults at High Risk for Pneumonia
    Johnstone, Jennie
    Eurich, Dean T.
    Minhas, Jasjeet K.
    Marrie, Thomas J.
    Majumdar, Sumit R.
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (01) : 15 - 22
  • [24] Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Sezaki, Hitomi
    Akuta, Norio
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Mineta, Rie
    Suzuki, Yukiko
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (05) : 641 - 651
  • [25] Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs
    Fumitaka Suzuki
    Yoshiyuki Suzuki
    Tetsuya Hosaka
    Hitomi Sezaki
    Norio Akuta
    Shunichiro Fujiyama
    Yusuke Kawamura
    Masahiro Kobayashi
    Satoshi Saitoh
    Yasuji Arase
    Kenji Ikeda
    Mariko Kobayashi
    Rie Mineta
    Yukiko Suzuki
    Hiromitsu Kumada
    Journal of Gastroenterology, 2017, 52 : 641 - 651
  • [26] Therapy for chronic Hepatitis B: Antiviral long-term therapy with Entacavir leads to decline of liver fibrosis in a case of chronic Hepatitis B
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2009, 47 (03): : B2 - B4
  • [27] Body-mass index is associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B
    Seto, W. -K.
    Fung, J.
    Cheung, K. -S.
    Mak, L. -Y.
    Hui, R. W. H.
    Liu, K. S. H.
    Lai, C. -L.
    Yuen, M. -F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (10) : 1071 - 1079
  • [28] LONG-TERM EFFICACY AND IMPACT ON HEPATOCELLULAR CARCINOMA DEVELOPMENT OF NUCLEOSIDE ANALOGUE TREATMENT WITH LAMIVUDINE AND ENTECAVIR FOR CHRONIC HEPATITIS B AND CIRRHOSIS
    Kobashi, H.
    Miyake, Y.
    Ikeda, F.
    Yasunaka, T.
    Nishino, K.
    Moriya, A.
    Kubota, J. -I.
    Nakamura, S.
    Takaki, A.
    Nouso, K.
    Yamada, G.
    Yamamoto, K.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S291 - S292
  • [29] Long-Term Impact of Antiviral Therapy in the Natural History of Chronic Hepatitis C
    Cordero-Ruiz, Patricia
    Carmona-Soria, Isabel
    Caunedo-Alvarez, Angel
    Herrerias, Juan M.
    Vilches-Arenas, Angel
    GASTROENTEROLOGY, 2014, 146 (05) : S256 - S256
  • [30] Efficacy of long-term lamivudine therapy in HBeAg negative chronic hepatitis B
    Dimou, E
    Papatheodoridis, GC
    Laras, A
    Rapti, I
    Dourakis, S
    Hadziyannis, SJ
    HEPATOLOGY, 1999, 30 (04) : 646A - 646A
12345